Improving Appropriateness of RBC Transfusion for Iron Deficiency Anemia Patients Presenting to the Emergency Department

2017 ◽  
Vol 31 (3) ◽  
pp. 194
Author(s):  
Fatima Khadadah ◽  
Jeannie Callum ◽  
Dominick Shelton ◽  
Yulia Lin
CJEM ◽  
2016 ◽  
Vol 19 (3) ◽  
pp. 167-174 ◽  
Author(s):  
Jordan Spradbrow ◽  
Yulia Lin ◽  
Dominick Shelton ◽  
Jeannie Callum

AbstractObjectivesThree are no clinical practice guidelines that specifically address the management of patients with iron deficiency anemia (IDA) in the emergency department (ED). The goal of this study was to describe the characteristics of IDA patients who present to the ED, documentation of IDA by emergency physicians, utilization of iron supplementation, and the appropriateness of red blood cell (RBC) transfusions ordered in the ED.MethodsA retrospective medical chart review was performed of IDA patients who visited the ED of a large tertiary center over a three-month period. Appropriateness of RBC transfusion was determined using a novel algorithm developed by our institution.ResultsOver the study period, there was a 0.3% (49/14,394) prevalence of IDA in the ED. In thirty (30/49; 61%) patients, IDA was documented by an emergency physician. RBC transfusions were administered to 19 patients; 10 transfusions (53%) were appropriate, 3 (16%) were appropriate for indication, but more than the required number of units were ordered, and 6 (32%) were inappropriate. Of the patients discharged, one (1/25; 4%) patient received intravenous iron in the ED and 6 of the 11 patients (55%) that were not already taking oral iron received a prescription at discharge from the ED.ConclusionsThis assessment demonstrated that management of IDA patients presenting to the ED may represent an important knowledge-to-practice gap. It revealed that RBC transfusion may be over-utilized and could be replaced by safer, lower-cost alternatives such as intravenous and oral iron. Guidelines for management of IDA in the ED may be necessary to achieve consistent IDA management and avoid inappropriate use of RBC transfusion.


2019 ◽  
Vol 57 (5) ◽  
pp. 637-645 ◽  
Author(s):  
Stephen Boone ◽  
Jacquelyn M. Powers ◽  
Boone Goodgame ◽  
W. Frank Peacock

2019 ◽  
Vol 15 (4) ◽  
pp. 629-634 ◽  
Author(s):  
Irene Motta ◽  
Giulia Mantovan ◽  
Dario Consonni ◽  
Anna Maria Brambilla ◽  
Maria Materia ◽  
...  

Blood ◽  
2021 ◽  
Vol 138 (Supplement 1) ◽  
pp. 2011-2011
Author(s):  
Matthew Speckert ◽  
Lana Ramic ◽  
Nicholas Mitsakakis ◽  
Mira Liebman ◽  
Elaine W. Leung

Abstract Introduction: Severe iron deficiency anemia (IDA) is a problem that often presents to the pediatric emergency department (ED). Recently published ASH-ASPHO Choosing Wisely recommendations suggest avoidance of transfusion in hemodynamically stable, asymptomatic children with IDA 1. Little is known about the use of parenteral iron in this pediatric setting. Methods: We undertook a retrospective review of patients with severe IDA treated in the pediatric ED at the Children's Hospital of Eastern Ontario (CHEO) from September 2017 to June 2021. During this period there were an estimated 75000 patients seen annually. Patients with severe IDA were defined as those presenting with hemoglobin (Hb) less than <70 g/L and low mean corpuscular volume. Results: There were 56 patients that met this criterion with presenting Hb ranging from 17-69 g/L (IQR 41- 62). Median age at presentation was 3.75 yrs (IQR 1.68- 15.5), with a bimodal peak at age 1 yr and again in the teen years (Fig 1). 42 (75%) patients were female. The most common causes of IDA were nutritional and heavy menstrual bleeding. 14 (24.6%) received packed red blood cell (PRBC) transfusion with or without parenteral iron (iron sucrose), and 11 (19.3%) were treated with parenteral iron alone. Almost all (55, 98.2%) were prescribed oral iron supplementation. The lower the presenting Hb, the more likely that transfusion or parenteral iron was used as initial therapy (Fig 2). 19 (33.9%) patients were admitted to hospital and 37 (66.1%) were discharged home from the ED. Nine recipients of parenteral iron alone had follow-up at CHEO, six had follow-up within 10 days with Hb increases of at least 20 g/L and all nine patients had follow-up by day 41 showing increases ranging from 20-97 g/L. Three recipients of parenteral iron alone had presenting Hb <30 g/L and by 9 days following ED encounter all three had increased their Hb by at least 20 (20-32) g/L. Three patients were discharged from ED after IV iron, and none presented to the ED again. Six recipients of PRBCs had follow up within 10 days showing Hb increase ranging from 33-62 g/L, only five had follow-up by day 41 showing increases of 42-79 g/L. Five patients received >1 transfusion, and transfused volumes ranged from 5-25 mL/kg. Minor infusion reactions occurred in 2 (17%) recipients of parenteral iron, and no patient was suspected to have anaphylaxis. Four (28.5%) patients experienced minor transfusion reactions to packed cells. One recipient of multiple PRBC transfusions had transfusion-associated cardiac overload (TACO) requiring ICU admission. Conclusions: This study demonstrates that patients with severe IDA can be safely and effectively managed in the ED setting with parenteral iron therapy alone without PRBC transfusion. The use of parenteral iron avoids the potential short and long-term complications associated with transfusion, whilst ensuring rapid restoration of iron stores without the tolerability issues associated with oral iron. Figure 1 Figure 1. Disclosures No relevant conflicts of interest to declare. OffLabel Disclosure: IV iron sucrose is indicated for treatment of iron deficiency in patients 2 and older with CKD. The use of it outside of this context would be considered off label.


Hematology ◽  
2019 ◽  
Vol 2019 (1) ◽  
pp. 323-326 ◽  
Author(s):  
Julia G. Ramos ◽  
Michelle P. Zeller

Abstract A 45-year-old woman with a history of uterine fibroids and abnormal uterine bleeding presents to the emergency department (ED) with presyncope and weakness. A gynecology consultation for definitive management was requested. The complete blood count demonstrates a hemoglobin (Hb) of 6.5 g/dL and a mean corpuscular volume (MCV) of 65 fL. What is the role of IV iron in managing iron-deficiency anemia (IDA) presenting to the ED/urgent care?


Transfusion ◽  
2018 ◽  
Vol 58 (8) ◽  
pp. 1902-1908 ◽  
Author(s):  
Fatima Khadadah ◽  
Jeannie Callum ◽  
Dominick Shelton ◽  
Yulia Lin

Blood ◽  
2015 ◽  
Vol 126 (23) ◽  
pp. 4454-4454 ◽  
Author(s):  
Tal Ben-Ami ◽  
Mohammad Natour ◽  
David Rekhtman ◽  
Tenenbaum Ariel ◽  
Shoshana Revel-Vilk

Abstract Background: Anemia is a global public health problem affecting both developing and developed countries. Most literature on severe anemia in children is reported from developing countries, where malaria infection and malnutrition are the main causative factors. According to the world health organization (WHO) report, in Israel, as in many western countries, anemia is considered a mild public health problem (1). The aim of this study it to analyze the causative factors and management of severe anemia in children living in a country where anemia is not considered a major health problem. Methods: The electronic hospital records of all children (≤16 years) with hemoglobin < 7.0 g/dl presenting to two largest Emergency Department (ED) in Jerusalem from 2008 to 2013 were retrospectively reviewed. Data including demographic characteristics, presenting signs and symptoms, laboratory findings, causal factors and management were extracted from medical records and analyzed. Cases secondary to surgical bleeding, chemotherapy, known chronic anemia or developing during prolonged admission were excluded. The diagnosis of iron deficiency anemia was based on low plasma iron and ferritin levels with compatible blood smear, when available. If unavailable, the diagnosis was based on the findings of low MCV and MCH for age with increased RDW. Results: A total of 227 children (female 123, 54%) at a median (range) age at of 4.5 years (1 day-15.5 years) were included. The median (range) hemoglobin at presentation was 6.3 (2.6-6.9) g/dl. In the entire cohort the most common etiologies for severe anemia were iron deficiency anemia (IDA) (38%) and acute hemolysis; autoimmune (AIHA) (8.5%) or G6PD deficiency (8%). The distribution of etiologies for severe anemia differed between infants, pre-school age, school age and adolescents (Figure 1). While the diagnosis of IDA was the most common in all age groups, some diagnoses such as G6PD deficiency and congenital anemia were more common in the younger age groups (up to 6 years) compared to the older ages. Children diagnosed with IDA were significantly older; median (range) 9.5 years (4 months-15.5 years), compared to children with other diagnoses, 3 years (1 day-15.5 years) (p<0.001), with a trend for more females diagnosed with IDA, 53/85 (62%) compared to other diagnosis, 70/142 (51%) (p=0.056). Transfusion of red blood cells (RBCs) was used as a sole or part of treatment in 144 (63%) children. In the entire cohort the use of RBCs transfusion was associated with lower baseline hemoglobin levels and higher heart rate at presentation, but not with the child's age. A third of children with IDA received RBCs transfusion. In this subgroup, the use of RBC transfusion was associated with underlying disease and baseline higher MCV. The OR (95% CI) for receiving RBC transfusion in children with underlying disease was 3.05 (1.16-7.94). The use of RBC transfusion was not associated with age, gender, heart rate at presentation and hemoglobin levels. In adolescents with menorrhagia, almost all those admitted to the Gynecology Department (10/11) received RBC transfusion compared to a third (5/17) of those admitted to the Pediatric Department (p=0.001). No other differences, i.e. history of acute blood loss, heart rate at presentation, hemoglobin level and MCV, were found between groups. Discussion: The distribution of etiologies for severe anemia in our cohort is different compared to the publications from developing countries. Still, iron deficiency, a potentially preventable medical problem, is the leading cause for those cases. The use of RBCs transfusion in almost a third of children with IDA may result in unnecessary transfusion related complications. The association of RBCs transfusion with underlying disease, higher MCVand admitting department may reflect the physicians' decision process. Improved attempts for prevention of IDA in all aged children and guidelines for RBCs transfusion in children presenting with anemia to the ED are needed. (1) Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. Available from: whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf. Figure 1. Etiologies for presentation of children in the Emergency Department with severe anemia (hemoglobin < 7 gr/dl) per age groups * "Other" (<10 cases each in the entire cohort), e.g. chronic renal failure, acute infection and metabolic diseases, etc. Figure 1. Etiologies for presentation of children in the Emergency Department with severe anemia (hemoglobin < 7 gr/dl) per age groups * "Other" (<10 cases each in the entire cohort), e.g. chronic renal failure, acute infection and metabolic diseases, etc. Disclosures No relevant conflicts of interest to declare.


Sign in / Sign up

Export Citation Format

Share Document